Richard H. Greenberg

863 total citations
10 papers, 229 citations indexed

About

Richard H. Greenberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Richard H. Greenberg has authored 10 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Richard H. Greenberg's work include Cancer Treatment and Pharmacology (4 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Richard H. Greenberg is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Richard H. Greenberg collaborates with scholars based in United States and Canada. Richard H. Greenberg's co-authors include Mark Kaplan, Robert G. Somers, C. Stern, Leonard G. Gomella, Rodolfo Bordoni, Chandra P. Belani, G. R. Hudes, Sundar Ramalingam, C McAleer and David Waterhouse and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Richard H. Greenberg

10 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard H. Greenberg United States 7 152 112 44 37 32 10 229
Masakazu Kojika Japan 6 128 0.8× 142 1.3× 121 2.8× 49 1.3× 60 1.9× 8 328
M. Toubis Greece 7 239 1.6× 234 2.1× 83 1.9× 26 0.7× 39 1.2× 12 373
J. Arends Netherlands 6 66 0.4× 84 0.8× 79 1.8× 64 1.7× 36 1.1× 8 251
Jiangjiao Zhou China 13 111 0.7× 113 1.0× 55 1.3× 109 2.9× 48 1.5× 23 359
Jinlin Hu China 10 85 0.6× 71 0.6× 68 1.5× 49 1.3× 15 0.5× 16 242
Vérane Achard Switzerland 10 263 1.7× 87 0.8× 79 1.8× 24 0.6× 18 0.6× 37 359
Kong Fan-min China 11 71 0.5× 64 0.6× 71 1.6× 114 3.1× 35 1.1× 20 268
Sean V. McGarry United States 6 69 0.5× 82 0.7× 76 1.7× 40 1.1× 11 0.3× 9 192
J. Good United Kingdom 8 73 0.5× 95 0.8× 98 2.2× 33 0.9× 41 1.3× 14 296
Xiaohui Qian China 10 68 0.4× 71 0.6× 119 2.7× 39 1.1× 28 0.9× 23 274

Countries citing papers authored by Richard H. Greenberg

Since Specialization
Citations

This map shows the geographic impact of Richard H. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Greenberg more than expected).

Fields of papers citing papers by Richard H. Greenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Greenberg. The network helps show where Richard H. Greenberg may publish in the future.

Co-authorship network of co-authors of Richard H. Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Greenberg. A scholar is included among the top collaborators of Richard H. Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Greenberg. Richard H. Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Salami, Aitua, et al.. (2022). Early Prophylactic Gastrectomy for the Management of Gastric Adenomatous Proximal Polyposis Syndrome (GAPPS).. PubMed. 3(7). 62–68. 8 indexed citations
2.
Greenberg, Richard H., et al.. (2018). Anal dysplasia among solid organ transplant recipients; a cross sectional study. Journal of Coloproctology. 39(1). 56–61. 2 indexed citations
3.
Magliocco, Anthony, Jennifer Moughan, Jeffry Simko, et al.. (2017). The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.. International Journal of Radiation Oncology*Biology*Physics. 99(2). S117–S118. 5 indexed citations
4.
Magliocco, Anthony, Jennifer Moughan, Jeff Simko, et al.. (2017). The impact of MRE11 in nuclear to cytoplasmic ratio on outcomes in muscle invasive bladder cancer an analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.. Journal of Clinical Oncology. 35(6_suppl). 343–343. 9 indexed citations
5.
Thomas, Sachdev, Suprith Badarinath, Richard H. Greenberg, et al.. (2012). MAVERICC: A randomized phase II study of mFOLFOX6-bevacizumab (BV) versus FOLFIRI-BV with prospective biomarker stratification in previously untreated metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 30(15_suppl). TPS3635–TPS3635. 5 indexed citations
6.
7.
Czuczman, M. S., Craig B. Reeder, Jonathan Polikoff, et al.. (2008). International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology. 26(15_suppl). 8509–8509. 9 indexed citations
8.
9.
Hudes, G. R., Faith E. Nathan, Richard H. Greenberg, et al.. (1995). Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer.. PubMed. 22(5 Suppl 12). 41–5. 59 indexed citations
10.
Acheson, R. M., et al.. (1969). NEW HAVEN SURVEY OF JOINT DISEASE. American Journal of Epidemiology. 90(3). 224–235. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026